India's largest dental chain, Clove Dental, is hitting record revenues and on track for its best quarter ever despite Covid. HBI caught up with Clove chairman and co-founder Louis Shakinovsky at HBI 2021 to find out more.
There were strong opinions at HBI 2020 on the key question as to whether NHS activity in the UK will ever return to pre-pandemic levels; UK CEOs and investors at HBI 2021 were less than optimistic about its chances, but double digit private growth is filling the gap.
The mass consolidation of the past decade has seen the creation of Pan-European dental chains. But how far has that been disrupted by Covid? What have dental groups had to change about their models to deal with pent-up demand? What digital interventions should dental groups be investing in? Confirmed speakers include: Ben Faircloth, L.E.K. Consulting […]
Pan-European dental group Curaeos has been sold by EQT and minority stakeholders to family-owned Colosseum Dental Group, creating Europe's largest dental group by revenue. HBI speaks to a Europe-based operator to find out more.
HBI’s inaugural HBI Health Care Services Top 100 lists the largest 100 companies by EMEA health care services revenue. In total revenue their revenue came to over €105bn - and we've uncovered some surprising winners and losers.
The pandemic is causing many businesses and their investors to reassess their plans - and their portfolios. HBI speaks to Ray Berglund, Head of European Healthcare and Life Sciences at management consultants Alvarez & Marsal, and his colleague and Managing Director Dominic Orchard, about why they have never been busier, and the clear trend they are seeing towards carve-outs.
The future of the UK NHS is changing according to the recent White Paper and Queen's Speech - we're moving towards collaboration not competition and a Secretary of State for Health with wider powers. But current incumbent Matt Hancock's reputation is damaged and his political capital on the wane. HBI heard at a Kings Fund digital event that this could prove a problem for the NHS.
Palamon Capital, the minority shareholder of dental group IDH/mydentist has bought majority control from Carlyle. Bridgepoint had earlier bought the group for £700m but Palamon has now exercised a right of first offer to push it out of the sale.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.